Note: Ingredients listed on restricted chemical lists
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
>=0,036-< >=0,036%
EC/CAS
232-577-1
Name of the chemical
Catalase
Concentration
>=5-<10
General Information
Version
3.0
Revision date
2024-11-21
Product name
Zenix DZ4015 Contaminant Control Agent
1.2.1 Relevant identified uses
Production aid for use in the pulp & paper industry
Emergency telephone
+1-302-502-0991, +431 406 43
Icons in SDS
Company Information
company name
Solenis Netherlands B.V
e-mail address of the competent person responsible for the Safety Data Sheet
EHSProductSafetyTeam@solenis.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Prevention
P261 Avoid breathing mist or vapors. P280 Wear protective gloves. P284 Wear respiratory protection.
Response
P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor. Hazardous ingredients which must be listed on the label: CATALASE 1,2-benzisothiazol-3(2H)-one
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Respiratory sensitization, Category 1 H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled. Skin sensitization, Category 1 H317: May cause an allergic skin reaction.
